Advertisement

Pharmacy World and Science

, Volume 16, Supplement 5, pp 3–12 | Cite as

Abstracts of papers

  • Tognoni G. 
  • Charles Medawar
  • M. Romero
  • F. Venturini
  • R. Di Pasquale
  • M. Font
  • J. -P. Boissel
  • Alessandro Liberati
  • R. Rampazzo
  • G. Scroccaro
  • Valter Torri
  • R. Fossati
  • A. Liberati
  • S. Marsoni
  • J. Altimiras
  • R. Di Pasquale
  • C. Cattaruzzi
  • L. Aqostinis
  • M. Maggini
  • L. A. Garcia Rodriguez
  • R. Raschetti
  • G. Simon
  • M. G. Troncon
  • Andrew Herxheimer
  • Mignot G. 
  • Bardelay D. 
  • G. F. Nasi
  • M. Bonati
  • Messori A. 
  • Li Wan Po A. 
  • Rampaszo R. 
  • M. van Hooreweghe
  • H. Robays
  • J. Rømsing
  • J. Møller-Sonnergaard
  • S. Hertel
  • M. Rasmussen
  • Sybil Todd
  • Sally Nuessle
  • I. Carlen
  • M. Tanner
  • C. Reinke
  • S. Marty
  • S. Saponaro
  • R. Luzzi
  • Claesson C. B. 
  • Cornelius C. 
  • Thorslund M. 
  • Winblad B. 
  • Hubert G. Leufkens
  • Eibert R. Heerdink
  • Albert Bakker
  • M. C. J. M. Sturkenboom
  • A. Middelbeek
  • L. T. W. de Jong van den Berg
  • PB van den Berg
  • BHCh Stricker
  • Silvio Garattini
  • G. Conti
  • G. Hazebroucq
  • Raza A. 
  • D. Labbrozzi
  • A. Nicolucci
  • Behalf of the Gruppo Italiano per l'Apnlicazione della Dichiarazione di S.Vincent
  • Wiklund Ingela
  • Carlo Lucioni
  • M. S. Salek
  • A. R. Griffith
  • C. Spiller
  • D. K. Luscombe
  • A. J. Bayer
Article
  • 50 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kramer M.S. Clinical epidemiology and biostatistics. Springer-Verlag. 1988, Springer-Verlag, New York, Berlin, Heilderberg.Google Scholar
  2. Schlesselman J.J. Case Control Studies, design, conduct, analysis. Oxford University Press, 1982 New York.Google Scholar
  3. Strom B.L. (edit). Pharmacoepidemiology Churchill Livingstone, 1989, New York.Google Scholar
  4. Hartzema A.G. Porta M.S. Tilson H.H. (edts). Pharmacoepidemiology: an introduction. Second edit. Harvey Whitney Books Company, 1991, Cincinnati.Google Scholar

References

  1. Garcia Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994; 154:311–316.PubMedGoogle Scholar
  2. Garcia Rodriguez LA, Pérez Gutthann S, Walker AM, Lueck L. The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ 1992; 305:865–868.PubMedGoogle Scholar

References

  1. Surendrakumar D., Hospital admission and the start of benzodiazepine use. Brit. Med. J. 1992; 304: 881PubMedGoogle Scholar
  2. Mathew A., Benzodiazepine Prescribing at Western Hospital. Aust. J. Hosp. Pharm. 1993; 23: 134–5Google Scholar
  3. Huston P., Moderating Benzodiazepine Use in the Elderly Con. Fam. Phys. 1992; 38: 2459–67Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1994

Authors and Affiliations

  • Tognoni G. 
    • 1
  • Charles Medawar
    • 2
  • M. Romero
    • 3
    • 10
  • F. Venturini
    • 3
    • 10
  • R. Di Pasquale
    • 3
  • M. Font
    • 4
  • J. -P. Boissel
    • 5
  • Alessandro Liberati
    • 6
  • R. Rampazzo
    • 7
  • G. Scroccaro
    • 7
  • Valter Torri
    • 8
  • R. Fossati
    • 8
  • A. Liberati
    • 8
  • S. Marsoni
    • 8
  • J. Altimiras
    • 9
  • R. Di Pasquale
    • 10
  • C. Cattaruzzi
    • 11
  • L. Aqostinis
    • 12
  • M. Maggini
    • 13
  • L. A. Garcia Rodriguez
    • 14
  • R. Raschetti
    • 13
  • G. Simon
    • 11
  • M. G. Troncon
    • 11
  • Andrew Herxheimer
    • 15
  • Mignot G. 
  • Bardelay D. 
  • G. F. Nasi
    • 16
  • M. Bonati
    • 17
  • Messori A. 
  • Li Wan Po A. 
  • Rampaszo R. 
  • M. van Hooreweghe
    • 18
  • H. Robays
    • 18
  • J. Rømsing
    • 19
  • J. Møller-Sonnergaard
    • 19
  • S. Hertel
    • 20
  • M. Rasmussen
    • 19
  • Sybil Todd
  • Sally Nuessle
  • I. Carlen
    • 22
  • M. Tanner
    • 23
  • C. Reinke
    • 24
  • S. Marty
    • 22
  • S. Saponaro
    • 25
  • R. Luzzi
    • 25
  • Claesson C. B. 
    • 28
  • Cornelius C. 
    • 26
  • Thorslund M. 
    • 27
  • Winblad B. 
    • 26
  • Hubert G. Leufkens
    • 29
  • Eibert R. Heerdink
    • 29
  • Albert Bakker
    • 29
  • M. C. J. M. Sturkenboom
    • 30
    • 31
  • A. Middelbeek
    • 30
    • 31
  • L. T. W. de Jong van den Berg
    • 30
    • 31
  • PB van den Berg
    • 30
    • 31
  • BHCh Stricker
    • 30
    • 31
  • Silvio Garattini
    • 32
  • G. Conti
    • 33
  • G. Hazebroucq
    • 21
  • Raza A. 
    • 34
  • D. Labbrozzi
    • 35
  • A. Nicolucci
    • 35
  • Behalf of the Gruppo Italiano per l'Apnlicazione della Dichiarazione di S.Vincent
  • Wiklund Ingela
    • 36
  • Carlo Lucioni
    • 37
  • M. S. Salek
    • 38
    • 26
  • A. R. Griffith
    • 38
  • C. Spiller
    • 38
  • D. K. Luscombe
    • 38
  • A. J. Bayer
    • 38
  1. 1.Istituto di Ricerche Farmacologiche “Mario Negri”MilanoItaly
  2. 2.Social Audit LtdLondonUK
  3. 3.Centro Studi SIFOConsorzio Mario Negri SudS. Maria Imbaro (Chicti)Italy
  4. 4.Settore Farmaceutico USL 25VeronaItaly
  5. 5.Service de Pharmacologie CliniqueLyon Cedex 3France
  6. 6.Laboratorio di Epidemiologia ClinicaIstituto di Ricerche Farmacologiche “Mario Ncgri”MilanoItaly
  7. 7.Policlinico HospitalVeronaItaly
  8. 8.Laboratorio di Epidemiologia Clinica dei TumoriIstituto di Ricerche Farmacologiche “Mario Negri”Milano
  9. 9.Pharmacy ServiceBarcelonaSpain
  10. 10.Centro Studi SIFOConsorzio M.Negri SudS.Maria Imbaro (Chieti)Italy
  11. 11.Direzione Regionale SanitàTrieste
  12. 12.INSIEL S.p.A.Udine
  13. 13.Lab. Epidem. Biost. Ist. Superiore SanitàRomaItaly
  14. 14.CEIFE, IUCA, Universidad ComplutenseMadridSpain
  15. 15.UK Cochrane CentreNHS Rs&D ProgrammeOxfordUK
  16. 16.Farmacie Comunali Riunite (FCR)Reggio EmiliaItaly
  17. 17.Laboratory for Mother and Child HealthIstituto di Ricerche Farmacologiche ‘Mario Negri’MilanoItaly
  18. 18.Pharmacy ServicesUniversity HospitalGentBelgium
  19. 19.Department of PharmaceuticsThe Royal Danish School of PharmacyCopenhagenDenmark
  20. 20.The State University Hospital of CopenhagenCopenhagenDenmark
  21. 21.King Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia
  22. 22.Zentralinstitut der Walliser SpitälerSwitzerland
  23. 23.Schwerzerisches TropeninstitutBasclSwitzerland
  24. 24.Pharmazeutisches Institut der Universität BaselBaselSwitzerland
  25. 25.Pharmacy ServiceUniversity Hospital of BariBariItaly
  26. 26.Stockholm Gerontology Research Center & Department of Geriatric MedicineKarolinska InstituteStockholmSweden
  27. 27.Department of Social MedicineUniversity HospitalUppsalaSweden
  28. 28.School of Social SciencesStockholm UniversityStockholmSweden
  29. 29.Department of Pharmacoepidemiology and PharmacolhcrapyUtrecht UniversityTB UtrechtThe Netherlands
  30. 30.Department of Social Pharmacy and PharmacoepidemiologyAW GroningenThe Netherlands
  31. 31.Center for Monitoring of Adverse Reactions to DrugsRijswijkThe Netherlands
  32. 32.Istituto di Ricerche Farmacologiche “Mario Negri”MilanItaly
  33. 33.EMEA - Committee for Veterinary DrugsThe Netherlands
  34. 34.Clinical Research Group, Medical Affairs Dept.Zeneca PharmaceuticalsAlderley ParkEngland
  35. 35.Laboratorio di Farmacologia Clinica ed EpidemiologiaConsorzio Mario Negri SudS. Maria Imbaro (Chieti)Italia
  36. 36.Behavioural MedicineAstra HässleSweden
  37. 37.Institute of Health EconomicsMilano
  38. 38.Division of Clinical Pharmacy and § Department of Geriatric MedicineUniversity of WalesCardiffUK

Personalised recommendations